Home> Products> advantage

{ "products": [ { "_id": "667e87308283510a74c61540", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DABIGATREX 150 ", "description": "Introduction to DABIGATREX 150 \nDABIGATREX 150 emerges as a groundbreaking anticoagulant, revolutionizing the prevention and treatment of blood clots with its precision and efficacy. In this comprehensive exploration, we delve into its mechanism, benefits, and practical considerations, offering insights into its pivotal role in modern medicine.\n\nWhat is DABIGATREX 150 ?\n\nDABIGATREX 150 , a potent anticoagulant, stands out in the pharmacological realm for its direct inhibition of thrombin, a critical enzyme in the clotting process. This section unveils its definition, overview, and the science that underscores its action.\n\nThe Science Behind DABIGATREX 150 \n\nAt the heart of DABIGATREX 150 's effectiveness is its unique mechanism of action, offering a detailed look into how it operates at the molecular level to prevent clot formation, distinguishing it from traditional anticoagulants.\n\nBenefits and Uses\n\nHighlighting the myriad benefits and uses of DABIGATREX 150 , this segment explores its key advantages in treating and preventing various thromboembolic disorders, setting new standards in anticoagulation therapy.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488\n BUY NOW\nhttps://www.sterisonline.com/product/dabigatrex-150-133288\n", "price": 290.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "BUY", "Uses", "EMAIL", "heart", "action", "segment", "section", "insights", "thrombin", "overview", "efficacy", "precision", "treatment", "prevention", "DABIGATREX", "definition", "The Science", "blood clots", "information", "Introduction", "sterisonline", "pivotal role", "sterispharma", "detailed look", "effectiveness", "CALL/WHATSAPP", "new standards", "key advantages", "clot formation", "myriad benefits", "molecular level", "critical enzyme", "modern medicine", "clotting process", "unique mechanism", "direct inhibition", "potent anticoagulant", "pharmacological realm", "anticoagulation therapy", "practical considerations", "comprehensive exploration", "traditional anticoagulants", "groundbreaking anticoagulant", "various thromboembolic disorders" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 989, "imageuri": "https://bizimages.withfloats.com/actual/6e3842a565cb4a7e8c0be1045dd40bb7.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/6e3842a565cb4a7e8c0be1045dd40bb7.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T09:49:36.902Z", "updatedon": "2024-06-28T09:49:36.902Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/dabigatrex-150-/989", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DABIGATRAN ETEXILATE", "category": "Cardiology range", "tags": [ "Dabigat 150 Capsule", "Pradaxa 150mg Capsule", "Dabistar 150 Capsule", "Afogatran 150 Capsule", "Dablexa 150 Capsule", "Dabiclot 150mg Capsule", "Dabifib 150 Capsule", "Macdaxa 150mg Capsule", "Dabigo 150mg Capsule", "Dabigza 150 Capsule", "Goodflo 150mg Capsule", "Dabitra 150 Capsule", "Dabisung 150mg Capsule", "Dabiten 150mg Capsule", "Dabipla 150mg Capsule" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667e63c3294305175cc16c36", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VORTOXTIME 10 ", "description": "VORTOXTIME 10 \nVortioxetine (10mg)\nIntroduction to VORTOXTIME 10\nVORTOXTIME 10 is a pharmaceutical product containing Vortioxetine, an antidepressant used primarily for the treatment of major depressive disorder (MDD). Each tablet contains 10mg of Vortioxetine, which works by modulating serotonin levels in the brain to improve mood and alleviate depressive symptoms.\n\nWhat is Vortioxetine?\nVortioxetine is a novel antidepressant that functions as a serotonin modulator and stimulator. Unlike traditional SSRIs (Selective Serotonin Reuptake Inhibitors), Vortioxetine not only inhibits the reuptake of serotonin but also directly modulates serotonin receptor activity. This dual action makes it effective in managing depression, with potential benefits in cognitive functions affected by depressive disorders.\n\nUses of VORTOXTIME 10\nVORTOXTIME 10 is prescribed for:\n\nMajor Depressive Disorder (MDD): To alleviate symptoms such as persistent sadness, loss of interest in daily activities, fatigue, and cognitive impairment.\nAnxiety Disorders: Though primarily for MDD, Vortioxetine may also be beneficial in managing anxiety symptoms in some patients.\nDosage and Administration\n\nStarting Dose: The typical starting dose of VORTOXTIME 10 is 10mg once daily, which can be adjusted based on the patient's response and tolerance.\nMaintenance Dose: After initial response, the dose may be maintained or adjusted between 5mg to 20mg per day.\nAdministration: VORTOXTIME 10 can be taken with or without food. Consistency in taking the medication at the same time each day is recommended for optimal results.\nSide Effects\nCommon side effects of VORTOXTIME 10 may include:\n\nNausea\nDiarrhea\nDry mouth\nDizziness\nConstipation\nLess common but more severe side effects can include:\n\nSerotonin syndrome (characterized by agitation, hallucinations, and increased heart rate)\nHyponatremia (low sodium levels)\nIncreased risk of bleeding, especially if taken with other medications that affect bleeding.\nPrecautions and Warnings\n\nAllergic Reactions: Patients with known allergies to Vortioxetine or any of its components should avoid this medication.\nPregnancy and Breastfeeding: The safety of VORTOXTIME 10 during pregnancy and breastfeeding has not been fully established. It should only be used if the potential benefits justify the potential risks.\nInteractions: VORTOXTIME 10 can interact with other medications such as MAO inhibitors, SSRIs, SNRIs, NSAIDs, and anticoagulants. Always inform your healthcare provider about all the medications you are taking.\nAlcohol: It is advisable to avoid alcohol while taking VORTOXTIME 10 as it can increase certain side effects like dizziness and impair cognitive functions.\nConclusion\nVORTOXTIME 10 (Vortioxetine 10mg) is an effective treatment option for managing major depressive disorder. Its unique mechanism of action offers advantages over traditional antidepressants, particularly in improving cognitive symptoms associated with depression. However, like all medications, it is essential to use it under the guidance of a healthcare professional to ensure safety and efficacy. Always discuss any concerns or side effects with your doctor to tailor the treatment to your specific needs.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/vortoxtime-10-134275", "price": 160.0, "discountamount": 48.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "MDD", "day", "5mg", "food", "mood", "20mg", "loss", "Uses", "brain", "SNRIs", "EMAIL", "tablet", "NSAIDs", "Nausea", "safety", "Dosage", "doctor", "Alcohol", "fatigue", "concerns", "bleeding", "Diarrhea", "Warnings", "guidance", "patients", "interest", "efficacy", "tolerance", "agitation", "Dry mouth", "same time", "allergies", "Pregnancy", "Dizziness", "stimulator", "heart rate", "depression", "advantages", "components", "VORTOXTIME", "Conclusion", "information", "dual action", "Precautions", "Consistency", "Less common", "Interactions", "Hyponatremia", "sterispharma", "Constipation", "sterisonline", "Introduction", "Breastfeeding", "CALL/WHATSAPP", "MAO inhibitors", "hallucinations", "anticoagulants", "specific needs", "Increased risk", "Administration", "optimal results", "potential risks", "anxiety symptoms", "daily activities", "initial response", "Maintenance Dose", "serotonin levels", "unique mechanism", "low sodium levels", "Vortioxetine 10mg", "other medications", "Anxiety Disorders", "traditional SSRIs", "persistent sadness", "Allergic Reactions", "potential benefits", "Serotonin syndrome", "cognitive symptoms", "Common side effects", "severe side effects", "healthcare provider", "serotonin modulator", "depressive symptoms", "cognitive functions", "cognitive impairment", "novel antidepressant", "depressive disorders", "typical starting dose", "pharmaceutical product", "healthcare professional", "major depressive disorder", "effective treatment option", "traditional antidepressants", "serotonin receptor activity", "Selective Serotonin Reuptake Inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 979, "imageuri": "https://bizimages.withfloats.com/actual/c1280b3fbfb6433c9755e81fc1dd2ce0.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/c1280b3fbfb6433c9755e81fc1dd2ce0.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T07:18:27.935Z", "updatedon": "2024-06-28T07:26:00Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/vortoxtime-10-/979", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Vortioxetine (10mg)", "category": "Neurology Range", "tags": [ "Vortioxetine 10 mg side effects", "Vortioxetine 10 Mg Sun Pharma", "Vortioxetine 10 mg price", "Vortioxetine uses", "Vortioxetine 10 mg uses in Hindi", "Vortioxetine 10 mg brand Name", "Vortioxetine side effects", "Vortioxetine 20 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "667ab7494e737218e092f8aa", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 500 ", "description": "IMEGLIMON 500 \nImeglimin Hydrochloride 500 mg\nIntroduction to IMEGLIMON 500\n\nImeglimin Hydrochloride 500 mg, marketed under the brand name IMEGLIMON 500, is an innovative medication that has recently garnered attention for its potential in treating type 2 diabetes. This pharmaceutical agent belongs to a new class of oral antidiabetic drugs and offers a unique mechanism of action, making it a valuable addition to the arsenal of diabetes management.\n\nMechanism of Action\n\nThe efficacy of IMEGLIMON 500 lies in its unique approach to enhancing insulin secretion and sensitivity, which are critical factors in the management of type 2 diabetes. Unlike other diabetes medications that primarily focus on a single aspect of glucose control, Imeglimin acts on multiple key organs involved in glucose regulation. This includes improving pancreatic β-cell function, enhancing muscle glucose uptake, and reducing liver glucose production. The dual action not only helps in reducing blood glucose levels but also aids in the overall management of glucose stability.\n\nClinical Efficacy and Safety\n\nClinical trials have demonstrated the effectiveness of IMEGLIMON 500 in lowering blood sugar levels in patients with type 2 diabetes. Studies highlight that when used alone or in combination with other diabetic medications, Imeglimin Hydrochloride 500 mg can significantly improve glycemic control. Moreover, the safety profile of IMEGLIMON 500 is commendable, with most adverse effects being mild to moderate in nature and similar to other well-tolerated diabetic medications. This makes IMEGLIMON 500 a safe choice for long-term use in managing diabetes.\n\nBenefits of IMEGLIMON 500\n\nOne of the significant advantages of IMEGLIMON 500 is its potential to address both the defects of insulin secretion and insulin resistance. By acting on multiple fronts, IMEGLIMON 500 not only helps in controlling blood sugar levels but also assists in mitigating common risks associated with diabetes, such as cardiovascular diseases. Furthermore, its ability to be combined with other diabetic treatments allows for flexible treatment plans tailored to individual patient needs, enhancing personalized medicine in diabetes care.\n\nPatient Considerations\n\nWhen considering IMEGLIMON 500 for diabetes management, it is essential for healthcare providers to evaluate each patient's overall health, including their medical history and other medications they are taking. This ensures the optimal effectiveness of IMEGLIMON 500 while minimizing potential drug interactions and side effects.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/imeglimon-500-134379", "price": 159.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "BUY", "EMAIL", "nature", "arsenal", "Studies", "defects", "patients", "Benefits", "new class", "IMEGLIMON", "attention", "brand name", "safe choice", "information", "sensitivity", "dual action", "combination", "common risks", "Introduction", "side effects", "sterisonline", "sterispharma", "single aspect", "CALL/WHATSAPP", "diabetes care", "long-term use", "safety profile", "overall health", "medical history", "type 2 diabetes", "multiple fronts", "glucose control", "unique approach", "Clinical trials", "glycemic control", "unique mechanism", "critical factors", "Clinical Efficacy", "glucose stability", "insulin secretion", "other medications", "valuable addition", "insulin resistance", "overall management", "glucose regulation", "blood sugar levels", "diabetes management", "multiple key organs", "healthcare providers", "blood glucose levels", "most adverse effects", "pharmaceutical agent", "muscle glucose uptake", "optimal effectiveness", "innovative medication", "personalized medicine", "significant advantages", "Patient Considerations", "cardiovascular diseases", "oral antidiabetic drugs", "individual patient needs", "liver glucose production", "flexible treatment plans", "other diabetic treatments", "other diabetes medications", "other diabetic medications", "pancreatic β-cell function", "potential drug interactions", "Imeglimin Hydrochloride 500 mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 964, "imageuri": "https://bizimages.withfloats.com/actual/cffc2d6bd3c84834b256a464bb54f946.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/cffc2d6bd3c84834b256a464bb54f946.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-25T12:25:45.323Z", "updatedon": "2024-06-27T12:44:41Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/imeglimon-500-/964", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Imeglimin Hydrochloride 500 mg", "category": "Diabetic Range", "tags": [ "imeglimin 500 uses in hindi", "imeglimin 500 price", "imeglimin 500 brands in india", "imeglimin 500 mechanism of action", "imeglimin 500 composition", "imeglimin 500 side effects", "imeglimin vs metformin", "imeglimin 500 class" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "66795e60e44fa41f7448a94a", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "REVOSTATIN CV 10 ", "description": "REVOSTATIN CV 10 \nRosuvastatin (10mg), Clopidogrel (75mg)\nDiscover the breakthrough in anticoagulation treatment with ROXARIVABEN 10, a cutting-edge medication designed to prevent and treat blood clots. In today's fast-paced world, where health is paramount, understanding how ROXARIVABEN 10 can play a crucial role in your wellness journey is more important than ever. This guide will take you through the essentials of ROXARIVABEN 10, showcasing its significance in modern medicine.\n\nThe Mechanism of Action: How ROXARIVABEN 10 Works\nROXARIVABEN 10 operates by selectively inhibiting Factor Xa, an essential component in the coagulation cascade that leads to blood clot formation. By targeting this specific factor, ROXARIVABEN 10 effectively reduces the risk of clot formation without the need for routine blood monitoring, making it a convenient and efficient option for those requiring long-term anticoagulation therapy.\n\nThe Versatility of ROXARIVABEN 10: Uses and Applications\nROXARIVABEN 10 is not just another medication; it's a versatile solution for various conditions associated with thromboembolic disorders. This section highlights the broad spectrum of applications for ROXARIVABEN 10, including the prevention of stroke in atrial fibrillation, treatment of deep vein thrombosis (DVT), and prevention of pulmonary embolism (PE), among others.\n\nEmbracing ROXARIVABEN 10: Benefits and Advantages\nChoosing ROXARIVABEN 10 comes with a myriad of benefits. Its once-daily dosing simplifies anticoagulation therapy, and its minimal food and drug interactions, compared to traditional anticoagulants, mark a significant advancement in patient care. Explore the comprehensive advantages of ROXARIVABEN 10 and how it can enhance your treatment experience.\n\nIntegrating ROXARIVABEN 10 into Your Healthcare Regimen\nIncorporating ROXARIVABEN 10 into your healthcare plan is straightforward. This guide provides insights into dosing schedules, potential interactions, and tips for managing your treatment, ensuring you can confidently navigate your health journey with ROXARIVABEN 10.\n For further information: \n \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488\nhttps://www.sterisonline.com/product/revostatin-cv-10-133364", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 952, "imageuri": "https://bizimages.withfloats.com/actual/7d7ea8e2071a433aacb2daa1d3d16c1e.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/7d7ea8e2071a433aacb2daa1d3d16c1e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-24T11:54:08.411Z", "updatedon": "2024-06-28T12:16:11Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/revostatin-cv-10-/952", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rivaroxaban (10mg)", "category": "Cardiology range", "tags": [ "Rosuvastatin (10mg), Clopidogrel (75mg)", "REVOSTATIN CV 10 mg", "Rosuvastatin 10mg", "Clopidogrel 75mg", "Clopidogrel 75mg uses", "Clopidogrel 75mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "6676c6373e891e1c784f73c5", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 500 ", "description": "VILDIABATE M 500 \nMetformin (500mg)SR, Vildagliptin (50mg)\nIntroduction\nType 2 diabetes management can be complex, requiring a regimen that effectively controls blood glucose levels while minimizing side effects and enhancing patient adherence. VILDIABATE M 500, which combines Metformin SR (500mg) with Vildagliptin (50mg), provides a potent dual therapy that targets key aspects of diabetes control. This article explores the benefits, mechanisms of action, and clinical advantages of using VILDIABATE M 500 for managing Type 2 diabetes.\n\nUnderstanding the Components of VILDIABATE M 500\nMetformin SR (500mg)\nMetformin, a cornerstone in diabetes treatment, primarily works by reducing hepatic glucose production and improving insulin sensitivity in muscle and fat tissues. The sustained-release (SR) formulation allows for a gradual release of the medication, minimizing gastrointestinal side effects and providing a stable, prolonged effect, which is crucial for maintaining consistent blood glucose levels throughout the day.\n\nVildagliptin (50mg)\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhancing the body's natural ability to control blood sugar levels post-meal. It works by inhibiting the enzyme that breaks down incretin hormones, thereby increasing their availability. Incretins help increase insulin release and decrease glucagon production in a glucose-dependent manner, effectively reducing postprandial glucose spikes.\n\nSynergistic Benefits for Diabetes Management\nComprehensive Glycemic Control\nVILDIABATE M 500 offers a comprehensive approach to managing blood glucose by targeting both fasting and postprandial levels. Metformin addresses fasting glucose by reducing liver glucose output and improving insulin sensitivity, while Vildagliptin controls postprandial spikes by enhancing the incretin effect.\n\nMinimized Risk of Hypoglycemia\nOne of the significant benefits of VILDIABATE M 500 is its low risk of causing hypoglycemia. Both Metformin and Vildagliptin do not typically induce hypoglycemia as they do not stimulate excessive insulin secretion. This makes VILDIABATE M 500 a safer option for patients, especially the elderly and those with renal impairment.\n\nWeight Management\nAnother advantage of VILDIABATE M 500 is its neutral impact on weight. Metformin has been known to aid in weight loss or maintain a neutral weight profile, and Vildagliptin does not contribute to weight gain. This aspect is particularly crucial in diabetes management, where weight control is often a key component of the overall treatment plan.\n\nIdeal Candidates for VILDIABATE M 500\nVILDIABATE M 500 is particularly suitable for individuals with Type 2 diabetes who:\n\nRequire an effective regimen to manage both fasting and postprandial blood glucose levels.\nAre concerned about the risks associated with hypoglycemia from other diabetes therapies.\nNeed a medication regimen that supports weight management.\nFor further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/vildiabate-m-500-133454", "price": 289.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "day", "body", "risks", "EMAIL", "500mg", "muscle", "action", "enzyme", "option", "fasting", "article", "patients", "low risk", "Incretins", "mechanisms", "Components", "weight loss", "weight gain", "fat tissues", "individuals", "information", "cornerstone", "key aspects", "Vildagliptin", "Metformin SR", "VILDIABATE M", "Introduction", "sterisonline", "availability", "sterispharma", "Hypoglycemia", "key component", "CALL/WHATSAPP", "neutral impact", "Minimized Risk", "weight control", "insulin release", "gradual release", "incretin effect", "natural ability", "Ideal Candidates", "DPP-4) inhibitor", "diabetes control", "renal impairment", "effective regimen", "patient adherence", "incretin hormones", "Weight Management", "medication regimen", "blood sugar levels", "diabetes treatment", "postprandial levels", "clinical advantages", "glucagon production", "postprandial spikes", "potent dual therapy", "insulin sensitivity", "liver glucose output", "Synergistic Benefits", "significant benefits", "neutral weight profile", "dipeptidyl peptidase-4", "overall treatment plan", "comprehensive approach", "glucose-dependent manner", "other diabetes therapies", "stable, prolonged effect", "hepatic glucose production", "Type 2 diabetes management", "postprandial glucose spikes", "excessive insulin secretion", "gastrointestinal side effects", "Comprehensive Glycemic Control", "consistent blood glucose levels", "postprandial blood glucose levels", "sustained-release (SR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 940, "imageuri": "https://bizimages.withfloats.com/actual/51bf714506634c868ec05400177b9bd5.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/51bf714506634c868ec05400177b9bd5.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-22T12:40:23.914Z", "updatedon": "2024-06-22T12:40:23.914Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/vildiabate-m-500-/940", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Metformin (500mg)SR, Vildagliptin (50mg)", "category": "Diabetic Range", "tags": [ "vildiabate m 500 uses in hindi", "vildapride m 50/500 alternative", "vildiabate m 1000", "vildapride m 50/1000", "vildapride m 500 tablet uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "66583a6d5418f50f8c646580", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "KETORENAL ALPHA SACHET ", "description": "KETORENAL ALPHA SACHET \nAlpha Ketoanalogue Sachet\nIntroduction to KETORENAL ALPHA SACHET\nKETORENAL ALPHA SACHET is a dietary supplement containing Alpha Ketoanalogue, which is used primarily to manage chronic kidney disease (CKD). Alpha Ketoanalogue supplements are designed to provide essential amino acids without increasing the nitrogen load, making them particularly beneficial for patients with impaired kidney function. By improving nutritional status and reducing the progression of kidney damage, KETORENAL ALPHA SACHET plays a crucial role in the dietary management of CKD.\n\nWhat is Alpha Ketoanalogue?\nOverview of Alpha Ketoanalogue\nAlpha Ketoanalogue is a compound that serves as a precursor to essential amino acids. In the body, Alpha Ketoanalogue is converted into essential amino acids without producing excess nitrogen, which is a significant advantage for patients with kidney disease. This conversion helps to maintain protein metabolism and nutritional status while minimizing the burden on the kidneys.\n\nMechanism of Action\nProtein Metabolism: Alpha Ketoanalogue provides the necessary building blocks for protein synthesis without adding to the nitrogen load, which helps maintain muscle mass and overall health.\nReduced Nitrogen Load: By converting into amino acids without producing additional nitrogen, Alpha Ketoanalogue reduces the risk of nitrogenous waste accumulation, which is particularly beneficial for CKD patients.\nBenefits of KETORENAL ALPHA SACHET\nNutritional Support for CKD Patients\nImproved Nutritional Status: KETORENAL ALPHA SACHET helps improve the nutritional status of CKD patients by providing essential amino acids required for protein synthesis.\nMuscle Mass Maintenance: By supporting protein metabolism, it helps maintain muscle mass and strength, which are often compromised in CKD patients.\nSlowing Progression of Kidney Disease\nReduced Nitrogenous Waste: The use of Alpha Ketoanalogue reduces the production of nitrogenous waste, which can help slow the progression of kidney damage.\nBetter Management of Uremia: By minimizing the accumulation of urea and other waste products, KETORENAL ALPHA SACHET helps manage symptoms of uremia in CKD patients.\nOverall Health Benefits\nEnhanced Energy Levels: Improved nutritional status and better protein metabolism can lead to enhanced energy levels and overall well-being.\nBalanced Diet: Incorporating KETORENAL ALPHA SACHET into the diet helps ensure a balanced intake of essential nutrients, which is crucial for CKD patients who often have dietary restrictions.\nHow to Use KETORENAL ALPHA SACHET\nDosage and Administration\nRecommended Dosage: The typical dosage of KETORENAL ALPHA SACHET is one sachet taken three times daily, or as directed by your healthcare provider. The exact dosage may vary based on individual needs and medical condition.\nAdministration: Dissolve the contents of one sachet in a glass of water or any other suitable liquid and consume immediately. It can also be mixed with food if preferred.\nGuidelines for Optimal Use\nRegular Intake: For best results, take KETORENAL ALPHA SACHET consistently as part of your daily dietary regimen.\nFollow Medical Advice: Always follow your healthcare provider’s instructions regarding dosage and dietary restrictions to achieve optimal benefits.\nWho Can Benefit from KETORENAL ALPHA SACHET?\nCKD Patients\nNutritional Management: Patients with chronic kidney disease who need to maintain their nutritional status without increasing the nitrogen load can benefit significantly from KETORENAL ALPHA SACHET.\nProtein Metabolism Support: Individuals with impaired kidney function who need support for protein metabolism and muscle mass maintenance.\nHealthcare Providers\nDietary Management Tool: Healthcare providers can use KETORENAL ALPHA SACHET as part of a comprehensive dietary management plan for CKD patients.\nConclusion\nKETORENAL ALPHA SACHET (Alpha Ketoanalogue Sachet) is an essential dietary supplement for managing chronic kidney disease. By providing essential amino acids without increasing the nitrogen load, it helps improve nutritional status, maintain muscle mass, and slow the progression of kidney damage. Always consult with your healthcare provider to determine if KETORENAL ALPHA SACHET is suitable for your specific health needs and to receive personalized dosage recommendations.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/ketorenal-alpha-134325", "price": 118.0, "discountamount": 36.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "risk", "CKD.", "body", "urea", "food", "part", "glass", "water", "Order", "EMAIL", "burden", "Uremia", "Action", "kidneys", "Overview", "compound", "contents", "symptoms", "strength", "precursor", "Mechanism", "conversion", "one sachet", "Guidelines", "production", "Conclusion", "Optimal Use", "information", "Individuals", "exact dosage", "CKD patients", "crucial role", "Introduction", "sterispharma", "instructions", "best results", "sterisonline", "CALL/WHATSAPP", "kidney damage", "Balanced Diet", "Administration", "typical dosage", "Medical Advice", "Regular Intake", "excess nitrogen", "balanced intake", "individual needs", "optimal benefits", "protein synthesis", "overall well-bein", "medical condition", "Better Management", "Recommended Dosage", "Slowing Progression", "additional nitrogen", "essential nutrients", "healthcare provider", "dietary restrictions", "other waste products", "other suitable liquid", "specific health needs", "daily dietary regimen", "essential amino acids", "Reduced Nitrogen Load", "significant advantage", "Enhanced Energy Levels", "chronic kidney disease", "Nutritional Management", "Muscle Mass Maintenance", "Dietary Management Tool", "Overall Health Benefits", "impaired kidney function", "Reduced Nitrogenous Waste", "necessary building blocks", "Alpha Ketoanalogue Sachet", "Protein Metabolism Support", "Improved Nutritional Status", "essential dietary supplement", "Alpha Ketoanalogue supplements", "nitrogenous waste accumulation", "personalized dosage recommendations", "comprehensive dietary management plan", "KETORENAL ALPHA SACHET Nutritional Support" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 919, "imageuri": "https://bizimages.withfloats.com/actual/b282ba60be9747d7b1c50a2bc3726aa9.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/b282ba60be9747d7b1c50a2bc3726aa9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-30T08:35:57.906Z", "updatedon": "2024-07-03T12:21:56Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/ketorenal-alpha-sachet-/919", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Alpha Ketoanalogue Sachet", "category": "Nephrology Range", "tags": [ "Alpha Ketoanalogue Tablets uses", "Alpha Ketoanalogue Tablet Price", "Alpha Ketoanalogue tablet dosage", "Alpha Ketoanalogue Tablet Brands", "Alpha Ketoanalogue in CKD", "Alpha Ketoanalogue and Essential amino acid tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "662cea5aa4eb611de48dd8ef", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VOGLIGOLD 0.2 ", "description": "VOGLIGOLD 0.2 \nVoglibose (0.2mg)\nIntroduction\nManaging postprandial blood glucose is a crucial aspect of controlling Type 2 diabetes and minimizing the risk of complications. VOGLIGOLD 0.2, containing 0.2mg of Voglibose, offers a targeted approach to managing glucose levels after meals. This article explores how Voglibose works, its benefits, and its role in the overall treatment regimen for diabetes patients.\n\nWhat is Voglibose?\nVoglibose is an alpha-glucosidase inhibitor, a class of oral antidiabetic drugs that play a crucial role in managing postprandial hyperglycemia (high blood sugar after eating). Unlike other diabetes medications that increase insulin secretion or enhance insulin sensitivity, Voglibose works by delaying the absorption of carbohydrates in the intestines. This action results in a more gradual rise in blood glucose levels following meals, making it an effective option for controlling spikes in blood sugar that are typical after eatin\n\nMechanism of Action\nVoglibose inhibits enzymes called alpha-glucosidases located in the intestinal brush border. These enzymes are responsible for breaking down complex carbohydrates into glucose. By inhibiting these enzymes, Voglibose slows down carbohydrate digestion and the consequent absorption of glucose. This leads to a significant reduction in the rate and extent of blood sugar rise after meals.\n\nBenefits of VOGLIGOLD 0.2\nImproved Postprandial Glucose Control\nVOGLIGOLD 0.2 is particularly effective in controlling blood sugar spikes after meals, a common challenge for many people with Type 2 diabetes. Regular use of Voglibose can help smooth out the daily peaks of blood glucose levels, which are linked to an increased risk of developing long-term diabetes complications.\n\nReduced Risk of Hypoglycemia\nBecause Voglibose acts by slowing glucose absorption and does not stimulate insulin secretion directly, it is associated with a lower risk of causing hypoglycemia compared to some other diabetes medications that increase insulin output from the pancreas.\n\nWeight Neutral\nVoglibose is considered weight neutral, meaning it does not contribute to weight gain. This is an important advantage since many individuals with Type 2 diabetes are also managing their weight as part of their overall health strategy.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/vogligold-0-2-133456", "price": 89.0, "discountamount": 26.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "part", "0.2mg", "EMAIL", "meals", "class", "action", "option", "extent", "article", "enzymes", "pancreas", "benefits", "Mechanism", "Voglibose", "VOGLIGOLD", "intestines", "lower risk", "daily peaks", "weight gain", "information", "Regular use", "many people", "Reduced Risk", "crucial role", "sterisonline", "gradual rise", "Hypoglycemia", "sterispharma", "Introduction", "CALL/WHATSAPP", "crucial aspect", "insulin output", "increased risk", "Weight Neutral", "Type 2 diabetes", "many individuals", "common challenge", "high blood sugar", "targeted approach", "diabetes patients", "insulin secretion", "blood sugar spikes", "glucose absorption", "important advantage", "insulin sensitivity", "blood glucose levels", "significant reduction", "consequent absorption", "complex carbohydrates", "carbohydrate digestion", "oral antidiabetic drugs", "intestinal brush border", "overall health strategy", "overall treatment regimen", "postprandial hyperglycemia", "postprandial blood glucose", "other diabetes medications", "alpha-glucosidase inhibitor", "long-term diabetes complications", "Improved Postprandial Glucose Control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 876, "imageuri": "https://bizimages.withfloats.com/actual/a7f3b4aa989a457894687d4ccf65500c.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/a7f3b4aa989a457894687d4ccf65500c.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-27T12:06:50.494Z", "updatedon": "2024-04-27T12:06:50.494Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/vogligold-0-2-/876", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Voglibose (0.2mg)", "category": "Diabetic Range", "tags": [ "Volibo", "Volix", "PPG", "Vobose", "Voglitor", "Vogli", "Voglistar", "Vozuca", "Voglinorm", "Voglimac" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662cd3769215811ea48e056c", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 1000 ", "description": "VILDIABATE M 1000 \nMetformin (1000mg)SR, Vildagliptin (50mg)\nIntroduction\nEffective management of Type 2 diabetes often involves the use of combination therapies that target different aspects of the disease to improve glycemic control. VILDIABATE M 1000 offers an advanced treatment solution by combining Metformin (1000mg) SR (Sustained Release) with Vildagliptin (50mg). This article examines the benefits and mechanisms of action of these two potent agents when used together, highlighting how they provide a synergistic effect to optimize diabetes management.\n\nUnderstanding the Components of VILDIABATE M 1000\nMetformin SR (1000mg)\nMetformin is one of the most prescribed medications for Type 2 diabetes and acts primarily by reducing the production of glucose in the liver, improving insulin sensitivity, and decreasing the intestinal absorption of sugar. The sustained-release formulation of Metformin in VILDIABATE M 1000 helps maintain steady medication levels in the blood, thereby reducing common gastrointestinal side effects and enhancing patient compliance.\n\nVildagliptin (50mg)\nVildagliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, which works by blocking the inactivation of incretin hormones. These hormones are released after a meal and increase insulin release and decrease glucagon production based on blood glucose levels. Vildagliptin helps manage the post-meal spikes in blood glucose, which are critical for overall glycemic control.\n\nSynergistic Benefits for Diabetes Management\nEnhanced Glycemic Control\nVILDIABATE M 1000 targets both fasting and postprandial blood glucose levels through its dual-action formula. Metformin addresses the baseline glucose production, while Vildagliptin specifically targets post-meal glucose spikes. This combination provides a comprehensive approach to managing blood sugar levels throughout the day.\n\nReduced Risk of Hypoglycemia\nThe combination of Metformin and Vildagliptin offers a significant advantage in terms of safety. Since both drugs do not typically cause hypoglycemia when used alone, their combination is also associated with a low risk of hypoglycemia compared to other therapies that increase insulin production regardless of blood glucose levels.\n\nWeight Management\nMetformin has been associated with weight loss or weight neutrality in many patients, which is a valuable benefit in diabetes management. Vildagliptin is weight-neutral, ensuring that the combination does not contribute to weight gain, a common concern with some other diabetes medications.\n\nIdeal Candidates for VILDIABATE M 1000\nVILDIABATE M 1000 is particularly suitable for individuals with Type 2 diabetes who:\n\nNeed to control both fasting and postprandial blood glucose levels effectively.\nMay have experienced gastrointestinal side effects with regular metformin.\nAre looking for a combination therapy that minimizes the risk of hypoglycemia.\nRequire a treatment that supports weight management efforts.\nDosage and Administration\nThe typical dosing of VILDIABATE M 1000 involves taking one tablet daily, preferably with a meal to reduce potential gastrointestinal issues and to optimize the absorption of the medications. It is important to follow healthcare guidance closely, as dosages may need to be adjusted based on individual response and kidney function.\nFor further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/vildiabate-m-1000-133453\n", "price": 319.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "day", "May", "use", "EMAIL", "drugs", "terms", "liver", "1000mg", "Dosage", "safety", "disease", "article", "fasting", "low risk", "mechanisms", "Components", "one tablet", "individuals", "weight loss", "weight gain", "information", "Metformin SR", "VILDIABATE M", "Reduced Risk", "Vildagliptin", "sterisonline", "inactivation", "Hypoglycemia", "sterispharma", "Introduction", "CALL/WHATSAPP", "many patients", "Administration", "typical dosing", "common concern", "Type 2 diabetes", "other therapies", "insulin release", "kidney function", "post-meal spikes", "valuable benefit", "Ideal Candidates", "Sustained Release", "regular metformin", "incretin hormones", "weight neutrality", "different aspects", "two potent agents", "patient compliance", "synergistic effect", "insulin production", "blood sugar levels", "individual response", "combination therapy", "healthcare guidance", "insulin sensitivity", "glucagon production", "dual-action formula", "diabetes management", "Synergistic Benefits", "Effective management", "significant advantage", "combination therapies", "intestinal absorption", "dipeptidyl peptidase-4", "DPP-4) inhibitor class", "comprehensive approach", "steady medication levels", "post-meal glucose spikes", "overall glycemic control", "Enhanced Glycemic Control", "weight management efforts", "other diabetes medications", "advanced treatment solution", "baseline glucose production", "sustained-release formulation", "potential gastrointestinal issues", "postprandial blood glucose levels", "common gastrointestinal side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 875, "imageuri": "https://bizimages.withfloats.com/actual/acabcbb5f8a242cfaa9a96e5bea0480d.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/acabcbb5f8a242cfaa9a96e5bea0480d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-27T10:29:10.348Z", "updatedon": "2024-04-27T10:29:10.348Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/vildiabate-m-1000-/875", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Metformin (1000mg)SR, Vildagliptin (50mg)", "category": "Diabetic Range", "tags": [ "Zomelis Met", "Vysov-M", "Vildagipt-MF", "Coniglip", "Vilglipt-M", "Valdiff-M", "Glipty M", "Vilcose M", "Vilayo M" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b9f829215811ea48e009e", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST-GLIPTIN M50/1000 ", "description": "ST-GLIPTIN M50/1000 \nSitagliptin (50mg), Metformin SR 1000\nIntroduction:\nDiabetes mellitus is a complex metabolic disorder that requires multifaceted treatment strategies to achieve optimal glycemic control and reduce the risk of complications. Sitagliptin and metformin are two widely used medications in the management of type 2 diabetes mellitus (T2DM), each with distinct mechanisms of action. ST-GLIPTIN M50/1000, a fixed-dose combination tablet containing sitagliptin (50mg) and extended-release metformin (1000mg), offers a synergistic approach to diabetes care. This article explores the features, efficacy, safety profile, and clinical implications of ST-GLIPTIN M50/1000 in the treatment of T2DM.\n\nUnderstanding Sitagliptin and Metformin SR:\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and decreases glucagon levels in a glucose-dependent manner, thereby improving glycemic control. Metformin, on the other hand, is a biguanide medication that primarily reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity. The extended-release formulation of metformin allows for once-daily dosing and may reduce gastrointestinal side effects compared to immediate-release formulations.\n\nKey Features of ST-GLIPTIN M50/1000:\nST-GLIPTIN M50/1000 is a fixed-dose combination tablet containing sitagliptin (50mg) and extended-release metformin (1000mg) in a standardized formulation. This combination offers the convenience of administering two effective antidiabetic agents in a single tablet, simplifying medication regimens and enhancing patient adherence. The complementary mechanisms of action of sitagliptin and metformin SR provide comprehensive glycemic control, addressing both fasting and postprandial hyperglycemia.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of ST-GLIPTIN M50/1000 in improving glycemic control in patients with T2DM. The combination of sitagliptin and metformin SR has been shown to reduce hemoglobin A1c (HbA1c) levels, fasting plasma glucose, and postprandial glucose excursions, leading to improvements in overall glucose regulation. Additionally, the extended-release formulation of metformin may offer advantages in terms of tolerability and gastrointestinal side effects compared to immediate-release formulations.\n\nSafety Profile:\nST-GLIPTIN M50/1000 exhibits a favorable safety profile, with adverse effects typically mild to moderate in severity. Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, which are often transient and diminish with continued use. Serious adverse events with ST-GLIPTIN M50/1000 are rare, and it is generally well-tolerated by most patients.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/st-gliptin-m50-1000-134014", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "risk", "T2DM", "mild", "terms", "EMAIL", "action", "dosing", "nausea", "article", "fasting", "efficacy", "severity", "diarrhea", "other hand", "advantages", "management", "moderate in", "Sitagliptin", "convenience", "information", "medications", "Metformin SR", "Introduction", "Key Features", "sterisonline", "sterispharma", "tolerability", "improvements", "complications", "most patients", "diabetes care", "single tablet", "continued use", "CALL/WHATSAPP", "HbA1c) levels", "hemoglobin A1c", "ST-GLIPTIN M50", "plasma glucose", "glucagon levels", "adverse effects", "DPP-4) inhibitor", "Clinical studies", "patient adherence", "insulin secretion", "medication regimens", "distinct mechanisms", "insulin sensitivity", "Common side effects", "abdominal discomfort", "biguanide medication", "synergistic approach", "clinical implications", "Serious adverse events", "dipeptidyl peptidase-4", "complementary mechanisms", "standardized formulation", "type 2 diabetes mellitus", "favorable safety profile", "optimal glycemic control", "glucose-dependent manner", "gastrointestinal symptoms", "peripheral glucose uptake", "postprandial hyperglycemia", "extended-release metformin", "overall glucose regulation", "hepatic glucose production", "complex metabolic disorder", "extended-release formulation", "fixed-dose combination tablet", "gastrointestinal side effects", "comprehensive glycemic control", "immediate-release formulations", "postprandial glucose excursions", "multifaceted treatment strategies", "two effective antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 871, "imageuri": "https://bizimages.withfloats.com/actual/0c9a83190d0d4a2dbc96152c3d2a99d8.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/0c9a83190d0d4a2dbc96152c3d2a99d8.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:35:14.3Z", "updatedon": "2024-04-26T12:35:14.3Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/st-gliptin-m50-1000-/871", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sitagliptin (50mg), Metformin SR 1000", "category": "Diabetic Range", "tags": [ "Sitalent M 50mg/1000mg Tablet SR", "Siglyn M 50/1000 Tablet SR", "Emsita M 50mg/1000mg Tablet SR", "Sitapride-M 50/1000 Tablet SR", "Sitabest-DMXR Tablet", "Sitahenz-M 1000 Tablet SR", "Siglinu M 50/1000 Tablet SR" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b9933e68e121fa8860acb", "fptag": "STERISHEALTHCAREPVTLTD8E4A", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET SR 850 ", "description": "SEIZMET SR 850 \nMetformin SR (850mg)\nIntroduction:\nDiabetes mellitus is a chronic metabolic disorder that requires lifelong management to prevent complications and improve quality of life. Metformin is considered a cornerstone in the treatment of type 2 diabetes mellitus (T2DM) due to its efficacy, safety profile, and cardiovascular benefits. SEIZMET SR 850, featuring Metformin sustained-release (SR) at a dosage of 850mg, offers a convenient and effective option for glycemic control. This article explores the features, efficacy, safety profile, and clinical implications of SEIZMET SR 850 in the management of T2DM.\n\nUnderstanding Metformin Sustained-Release (SR):\nMetformin SR is a formulation of metformin hydrochloride designed to release the medication gradually over time, allowing for once-daily dosin Its mechanism of action involves reducing hepatic glucose production, enhancing peripheral glucose uptake, and improving insulin sensitivity. By providing extended-release of the medication, Metformin SR offers more consistent blood glucose control and potentially fewer gastrointestinal side effects compared to immediate-release formulations.\n\nKey Features of SEIZMET SR 850:\nSEIZMET SR 850 is a pharmaceutical formulation containing Metformin SR at a standardized dosage of 850mg per tablet. This extended-release formulation allows for convenient once-daily dosing, simplifying medication regimens and enhancing patient adherence. The controlled release of metformin from SEIZMET SR 850 ensures steady plasma concentrations, providing continuous glycemic control throughout the day.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of Metformin SR, including SEIZMET SR 850, in improving glycemic control in patients with T2DM. Metformin SR has been shown to reduce hemoglobin A1c (HbA1c) levels, fasting plasma glucose, and postprandial glucose excursions, leading to improvements in overall glucose regulation. Additionally, the extended-release formulation may offer advantages in terms of tolerability and gastrointestinal side effects compared to immediate-release formulations.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/seizmet-sr-850-133444", "price": 38.0, "discountamount": 11.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "day", "T2DM", "time", "EMAIL", "terms", "850mg", "tablet", "action", "quality", "article", "efficacy", "patients", "mechanism", "treatment", "convenient", "seizmet-sr", "advantages", "potentially", "information", "cornerstone", "daily dosin", "sterisonline", "improvements", "tolerability", "sterispharma", "Introduction", "Metformin SR", "Key Features", "CALL/WHATSAPP", "complications", "HbA1c) levels", "plasma glucose", "safety profile", "SEIZMET SR 850", "hemoglobin A1c", "Clinical studies", "effective option", "patient adherence", "controlled release", "lifelong management", "standardized dosage", "medication regimens", "insulin sensitivity", "clinical implications", "cardiovascular benefits", "metformin hydrochloride", "type 2 diabetes mellitus", "peripheral glucose uptake", "overall glucose regulation", "hepatic glucose production", "chronic metabolic disorder", "pharmaceutical formulation", "Metformin sustained-release", "continuous glycemic control", "extended-release formulation", "steady plasma concentrations", "immediate-release formulations", "postprandial glucose excursions", "consistent blood glucose control", "fewer gastrointestinal side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 868, "imageuri": "https://bizimages.withfloats.com/actual/a506fa1e821b42f29ae681e2a761a4f0.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/a506fa1e821b42f29ae681e2a761a4f0.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:08:19.067Z", "updatedon": "2024-04-26T12:08:19.067Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/nagpur/medicines/seizmet-sr-850-/868", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Metformin SR (850mg)", "category": "Diabetic Range", "tags": [ "Metadoze-IPR 850 Tablet SR", "Glyciphage SR 850mg Tablet", "Metrose 850 SR Tablet", "Orva 850mg Tablet SR", "Riomet OD 850mg Tablet SR", "Arkamet Ipr 850mg Tablet SR", "Metasens 850 Tablet SR" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 10, "query": null, "floatingpoint": null }